Sunshine Biopharma Inc. Quarterly Return On Assets in % from Q3 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sunshine Biopharma Inc. quarterly/annual Return On Assets history and growth rate from Q3 2011 to Q3 2024.
  • Sunshine Biopharma Inc. Return On Assets for the quarter ending September 30, 2024 was -14.3 %, a 85.1% increase year-over-year.
  • Sunshine Biopharma Inc. annual Return On Assets for 2023 was -16.3 %, a 80.8% increase from 2022.
  • Sunshine Biopharma Inc. annual Return On Assets for 2022 was -85.2 %, a 85.6% increase from 2021.
  • Sunshine Biopharma Inc. annual Return On Assets for 2021 was -594 %, a 4.15% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -14.3 +81.1 +85.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -12.7 +75.2 +85.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -14.2 +64.1 +81.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -16.3 +68.9 +80.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -95.4 -84.9 -815% Jul 1, 2023 Sep 30, 2023
Q2 2023 -87.9 -53.6 -157% Apr 1, 2023 Jun 30, 2023
Q1 2023 -78.3 +72 +47.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -85.2 +508 +85.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -10.4 +775 +98.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -34.3 +789 +95.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -150 +838 +84.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -594 +25.7 +4.15% Oct 1, 2021 Dec 31, 2021
Q3 2021 -786 +200 +20.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -823 +743 +47.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -988 +499 +33.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -619 -204 -49.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -986 -744 -307% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.57K -1.33K -554% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.49K -1.31K -729% Jan 1, 2020 Mar 31, 2020
Q4 2019 -415 -220 -113% Oct 1, 2019 Dec 31, 2019
Q3 2019 -242 -12.3 -5.36% Jul 1, 2019 Sep 30, 2019
Q2 2019 -239 -50.5 -26.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -179 +85 +32.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -195 +398 +67.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -230 +1.31K +85.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -189 +1.4K +88.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -264 +683 +72.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -593 +31.9 +5.11% Oct 1, 2017 Dec 31, 2017
Q3 2017 -1.54K -1.11K -263% Jul 1, 2017 Sep 30, 2017
Q2 2017 -1.59K -1.32K -483% Apr 1, 2017 Jun 30, 2017
Q1 2017 -948 -580 -158% Jan 1, 2017 Mar 31, 2017
Q4 2016 -625 -39.9 -6.81% Oct 1, 2016 Dec 31, 2016
Q3 2016 -423 +512 +54.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -273 +647 +70.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -367 +970 +72.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -585 +1.17K +66.7% Oct 1, 2015 Dec 31, 2015
Q3 2015 -935 +1.79K +65.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -920 +2.97K +76.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -1.34K +469 +26% Jan 1, 2015 Mar 31, 2015
Q4 2014 -1.76K +147 +7.7% Oct 1, 2014 Dec 31, 2014
Q3 2014 -2.73K -1.45K -114% Jul 1, 2014 Sep 30, 2014
Q2 2014 -3.89K -2.82K -265% Apr 1, 2014 Jun 30, 2014
Q1 2014 -1.81K -694 -62.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -1.91K -1.43K -301% Oct 1, 2013 Dec 31, 2013
Q3 2013 -1.28K -646 -103% Jul 1, 2013 Sep 30, 2013
Q2 2013 -1.07K -584 -121% Apr 1, 2013 Jun 30, 2013
Q1 2013 -1.11K -721 -184% Jan 1, 2013 Mar 31, 2013
Q4 2012 -475 -123 -35.1% Oct 1, 2012 Dec 31, 2012
Q3 2012 -629 -1.89K -150% Jul 1, 2012 Sep 30, 2012
Q2 2012 -483 Apr 1, 2012 Jun 30, 2012
Q1 2012 -392 Jan 1, 2012 Mar 31, 2012
Q4 2011 -352 Oct 1, 2011 Dec 31, 2011
Q3 2011 1.26K Jul 1, 2011 Sep 30, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.